N. ., “Effect of SGLT2 inhibitor (Empagliflozin) on HbA1c in most Prevalent Age Group of Type 2 Diabetic Patients”, Int J Pathol, vol. 20, no. 4, pp. 178–181, Mar. 2023, Accessed: Dec. 07, 2025. [Online]. Available: https://www.jpathology.com.65-21-161-183.cpanel.site/index.php/OJS/article/view/802